Text Size

Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract

This study has been withdrawn prior to enrollment.
(Study redesigned and re-submitted to UAMS IRB under different study title and IRB number.)
Sponsor:
Information provided by:
Arkansas Children's Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT00578188
First received: December 19, 2007
Last updated: June 13, 2008
Last verified: June 2008
History of Changes
  Purpose

The purpose of this study is to determine if Chlamydial infections persist in the rectum of females who have had a sexually transmitted infection of Chlamydia.


Condition
Chlamydia Infection

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Arkansas Children's Hospital Research Institute:

Biospecimen Retention:   Samples With DNA

Serum, whole blood, tissue


Estimated Enrollment: 300
Study Start Date: February 2006
Estimated Study Completion Date: January 2008
Estimated Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
RP100-400
Subjects with Chlamydia. The control group will also be identified with these numbers.

  Eligibility

Ages Eligible for Study:   11 Years to 19 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

11-19 year old females from the Arkansas Children's Hospital Adolescent Center

Criteria

Inclusion Criteria:

  • 11-19 years old
  • Female
  • Diagnosis of Chlamydia on enrollment visit
  • Invitation to participate control group

Exclusion Criteria:

  • Age out of range
  • Negative Chlamydia screen (unless qualifies for control group)
  • Unable to provide needed samples
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00578188

Locations
United States, Arkansas
Arkansas Children's Hospital
Little Rock, Arkansas, United States, 72202
Sponsors and Collaborators
Arkansas Children's Hospital Research Institute
Investigators
Principal Investigator: Amy M Scurlock, MD Arkansas Children's Hospital Research Institute
  More Information

Additional Information:
Arkansas Children's Hospital Main Page  This link exits the ClinicalTrials.gov site

Publications:

Responsible Party: Amy Scurlock, MD, Arkansas Children's Hospital Research Institute
ClinicalTrials.gov Identifier: NCT00578188     History of Changes
Other Study ID Numbers: IRB # 43921, ACH GL #039005
Study First Received: December 19, 2007
Last Updated: June 13, 2008
Health Authority: United States: Federal Government

Keywords provided by Arkansas Children's Hospital Research Institute:
Adolescent Health
Sexually transmitted infection
Women's Health

Additional relevant MeSH terms:
Chlamydia Infections
Chlamydiaceae Infections
Gram-Negative Bacterial Infections
Bacterial Infections
Sexually Transmitted Diseases, Bacterial
 Sexually Transmitted Diseases
Infection
Genital Diseases, Male
Genital Diseases, Female

ClinicalTrials.gov processed this record on May 16, 2013